Timing of Antiretroviral Therapy for HIV-1-Associated Tuberculosis

被引:0
|
作者
Lawn, Stephen D. [1 ]
Wood, Robin [2 ]
机构
[1] London Sch Hyg & Trop Med, London WC1, England
[2] Univ Cape Town, ZA-7925 Cape Town, South Africa
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 05期
关键词
HIV-ASSOCIATED TUBERCULOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:474 / 474
页数:1
相关论文
共 50 条
  • [1] Timing of Antiretroviral Therapy for HIV-1-Associated Tuberculosis REPLY
    Blanc, Francois-Xavier
    Laureillard, Didier
    Goldfeld, Anne E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (05): : 475 - 475
  • [2] Treatment of HIV among tuberculosis patients: A replication study of timing of antiretroviral therapy for HIV-1-associated tuberculosis
    Djimeu, Eric W.
    Heard, Anna C.
    [J]. PLOS ONE, 2019, 14 (02):
  • [3] Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease
    Garvey, L.
    Winston, A.
    Walsh, J.
    Post, F.
    Porter, K.
    Gazzard, B.
    Fisher, M.
    Leen, C.
    Pillay, D.
    Hill, T.
    Johnson, M.
    Gilson, R.
    Anderson, J.
    Easterbrook, P.
    Bansi, L.
    Orkin, C.
    Ainsworth, J.
    Palfreeman, A.
    Gompels, M.
    Phillips, A. N.
    Sabin, C. A.
    [J]. NEUROLOGY, 2011, 76 (08) : 693 - 700
  • [4] Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
    Carr, A
    Marriott, D
    Field, A
    Vasak, E
    Cooper, DA
    [J]. LANCET, 1998, 351 (9098): : 256 - 261
  • [5] Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
    Havlir, Diane V.
    Kendall, Michelle A.
    Ive, Prudence
    Kumwenda, Johnstone
    Swindells, Susan
    Qasba, Sarojini S.
    Luetkemeyer, Anne F.
    Hogg, Evelyn
    Rooney, James F.
    Wu, Xingye
    Hosseinipour, Mina C.
    Lalloo, Umesh
    Veloso, Valdilea G.
    Some, Fatuma F.
    Kumarasamy, N.
    Padayatchi, Nesri
    Santos, Breno R.
    Reid, Stewart
    Hakim, James
    Mohapi, Lerato
    Mugyenyi, Peter
    Sanchez, Jorge
    Lama, Javier R.
    Pape, Jean W.
    Sanchez, Alejandro
    Asmelash, Aida
    Moko, Evans
    Sawe, Fred
    Andersen, Janet
    Sanne, Ian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1482 - 1491
  • [6] HIV-1-associated nephropathy and response to highly-active antiretroviral therapy
    Wali, RK
    Drachenberg, CI
    Papadimitriou, JC
    Keay, S
    Ramos, E
    [J]. LANCET, 1998, 352 (9130): : 783 - 784
  • [7] Effects of highly active antiretroviral therapy on HIV-1-associated oral complications
    Parveen, Zahida
    Acheampong, Edward
    Pomerantz, Roger J.
    Jacobson, Jeffrey M.
    Wigdahl, Brian
    Mukhtar, Muhammad
    [J]. CURRENT HIV RESEARCH, 2007, 5 (03) : 281 - 292
  • [8] The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction
    Kline, Erik R.
    Sutliff, Roy L.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (05) : 752 - 769
  • [9] Adjunctive treatment with etanercept in HIV-1-associated tuberculosis
    Wallis, RS
    Kyambadde, P
    Johnson, J
    Horter, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P110 - P110
  • [10] Antiretroviral therapy for HIV-associated tuberculosis
    Avihingsanon, Anchalee
    Hemachandra, Atchariya
    van de Lugt, Jasper
    [J]. ASIAN BIOMEDICINE, 2009, 3 (01) : 73 - 87